Wintac Ltd.
Wintac Ltd. (operating as Somerset Therapeutics Private Limited) is a Bengaluru-based, FDA-inspected pharmaceutical contract manufacturer producing sterile injectable and ophthalmic products for global multinational clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US.
- Company typePublic
- Founded1987
- HeadquartersBengaluru, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wintac Ltd. does
Wintac Ltd. is a Bengaluru, India-based pharmaceutical manufacturer that has operated since 1987 (operating under the Somerset Therapeutics Private Limited entity, CIN U85110KA1990PTC011166) and maintains an FDA-inspected sterile manufacturing facility with proven R&D capabilities in sterile injectables and ophthalmics. Its product portfolio spans large and small volume parenterals (vials from 1ml to 100ml and ampoules from 1ml to 10ml) covering therapeutic categories such as NSAIDs, calcium supplements, anti-emetics, analgesics, antimalarials, anesthetics, anti-infectives, antimuscarinics, diuretics, cardiovascular, antihistamines, and iron supplements, alongside an ophthalmic range including anti-glaucoma, anti-cholinergic, artificial tears, steroids, anti-infectives, anti-allergics, and decongestants. The company monetizes primarily through contract manufacturing services for multinational pharmaceutical clients — explicitly naming Sanofi-Aventis, Novartis, Bayer, and Alcon US as long-tenured customers — supplemented by in-house analytical services, dossier/CTD compilation, and formulation processing for the US market. Its facility has been approved by the US FDA and the French regulatory authority AFSSAPS, and the company operates a dedicated regulatory team supporting generic product development and global drug registration.
Wintac Ltd. firmographics
Firmographics- Name
- Wintac Ltd.
- Legal name
- Wintac Ltd.
- Website
- https://wintaclimited.com
- Company type
- Public
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Wintac Ltd. (operating as Somerset Therapeutics Private Limited) is a Bengaluru-based, FDA-inspected pharmaceutical contract manufacturer producing sterile injectable and ophthalmic products for global multinational clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US.
- Ownership category
- akta.pro rank
Wintac Ltd. industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
- akta.pro secondary industries
- Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces) (HLAAAJAG)
Keywords
Where Wintac Ltd. is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Markets served
Wintac Ltd. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Wintac Ltd. product offering
Product offeringCore offering
Wintac Ltd. operates an FDA-inspected sterile manufacturing facility focused on contract manufacturing of sterile injectable and ophthalmic pharmaceutical products. The company provides formulation, development, and commercial-scale production services for global pharmaceutical clients, leveraging cGMP-compliant operations and regulatory expertise.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Injectable Contract Manufacturing
Companies that use Wintac Ltd.
Customer profileIdeal customer profiles1 record
Wintac Ltd. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Wintac Ltd. partnerships and signals
Strategic signalScale indicators1 record
Wintac Ltd. competitors and assessment
Company assessmentRegional players
- Ajanta Pharma: India-based pharmaceutical manufacturer with ophthalmic and specialty product offerings serving emerging and regulated markets. Comparable on ophthalmic manufacturing capabilities and India-CDMO model.
- Hikal Ltd. India-based pharmaceutical manufacturer serving regulated markets with API and intermediate capabilities. Regionally and operationally comparable as another Indian pharma manufacturer serving global regulated customers.
Broad incumbents
- Lupin: Indian generic manufacturer with US FDA-approved injectable manufacturing and a broad product portfolio. Comparable on injectable manufacturing capabilities and regulated market supply, though much larger and more diversified.
- Dr. Reddy's Laboratories: Indian pharmaceutical manufacturer with a sterile injectables portfolio and US FDA-approved facilities. Comparable on injectable manufacturing and US market access, though diversified across multiple dosage forms and therapy areas.
- Cipla: Major Indian pharma company with sterile injectable and ophthalmic manufacturing capabilities. Comparable product overlap (injectables + ophthalmics) and similar India-based regulated market footprint, though at far larger scale.
- Aurobindo Pharma: Large Indian generic and injectable manufacturer with US FDA-approved sterile facilities serving regulated markets. Overlaps with Wintac on injectable manufacturing and US supply, but operates at materially greater scale and breadth.
Others
- Alcon: Global leader in ophthalmic pharmaceuticals and a stated customer of Wintac. Included as an adjacent ecosystem participant — both a customer and a benchmark for the ophthalmic capabilities Wintac has built.
Direct peers
- Strides Pharma Science: Indian pharma company with a focused sterile injectables (including ophthalmics) portfolio supplying the US market. Direct comparable on injectable focus, India manufacturing base, and US FDA-regulated supply model.
- Gland Pharma: India-based sterile injectable manufacturer and CDMO with US FDA-approved facilities supplying global pharma companies. Direct comparable on geography, manufacturing footprint, injectable focus, and customer profile.
Market position
Strengths4 records
Weaknesses4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wintac Ltd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wintac Ltd. leadership team
Management profileNumber of profiles
Profiles1 record
Wintac Ltd. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wintac Ltd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wintac Ltd.
What does Wintac Ltd. do?
Wintac Ltd. operates an FDA-inspected sterile manufacturing facility focused on contract manufacturing of sterile injectable and ophthalmic pharmaceutical products. The company provides formulation, development, and commercial-scale production services for global pharmaceutical clients, leveraging cGMP-compliant operations and regulatory expertise.
Is Wintac Ltd. a public or private company?
Wintac Ltd. is a public company. It is classified as public and is currently operating.
When was Wintac Ltd. founded?
Wintac Ltd. was founded in 1987. It employs 101 to 250 people.
Where is Wintac Ltd. based?
Wintac Ltd. is headquartered in Bengaluru, India, in the Asia region.
Who are Wintac Ltd.'s main competitors?
Regional players on record are Ajanta Pharma and Hikal Ltd.. Broad incumbents are Lupin, Dr. Reddy's Laboratories, Cipla and Aurobindo Pharma. Alcon is listed as an others. Direct peers are Strides Pharma Science and Gland Pharma.
Does Wintac Ltd. have an API?
No public API is recorded for Wintac Ltd..
What industry is Wintac Ltd. in?
Wintac Ltd.'s product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services, with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 325412 and its SIC code is 2834.